TheratOcular Biotek
PrivateLast Round
Corporate Funding
Jul 15, 2026
Total Funding Raised
$4.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
TheratOcular Biotek is a biotechnology company that develops user-friendly and cost-effective treatments for eye diseases using proprietary site-targeting drug delivery technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TheratOcular Biotek Comparables
Compare TheratOcular Biotek with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sunhawk Vision Biotech, Inc. | 82% | |
| Allgenesis Biotherapeutics Inc. | 82% | |
| Formosa Pharmaceuticals, Inc. | 77% |
TheratOcular Biotek Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jul 15, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2026
Raised $4.8M in a corporate funding round.
TheratOcular Biotek Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TheratOcular Biotek's valuation, stock price, and market status.
Is TheratOcular Biotek a public or private company?
TheratOcular Biotek is a private company.
What is the current stock price of TheratOcular Biotek?
TheratOcular Biotek is a private company, so its shares have no public market price. Caplight tracks TheratOcular Biotek's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TheratOcular Biotek worth (valuation)?
Valuation information for TheratOcular Biotek is not publicly available.
Can I buy TheratOcular Biotek stock?
TheratOcular Biotek shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TheratOcular Biotek's last funding round?
TheratOcular Biotek's most recent funding round was Corporate Funding on July 15, 2026.
Who are the main investors in TheratOcular Biotek?
Investor information for TheratOcular Biotek is not publicly disclosed.
Will TheratOcular Biotek IPO soon?
No public IPO plans have been announced for TheratOcular Biotek.
How can I track TheratOcular Biotek secondary market activity?
Caplight tracks bids, offers, and trades in TheratOcular Biotek's shares on secondary markets.